Photo

Photo detail

MannKind’s inhalable insulin device Afrezza.

Stories this photo appears in:

Inhalable Insulin Has Investors Breathing Heavy

HEALTH CARE: Expected FDA approval pumps up shares of MannKind.

Investors breathless over outlook for approval of MannKind’s inhalable insulin. 5

Tease photo

CEO Breathes Life Into Inhalable Insulin Maker

BIOTECH: Al Mann ups stake in MannKind as Afrezza trials continue.

MannKind owner’s equity move gives maker of inhalable insulin product some breathing room

Tease photo